BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1837473)

  • 1. Management of the febrile neutropenic patient with cancer.
    Gucalp R
    Oncology (Williston Park); 1991 Jul; 5(7):137-44, 147; discussion 148. PubMed ID: 1837473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia].
    Jarque I; Sanz MA
    Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():95-102. PubMed ID: 10605194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of mycoses in surgical patients -- review of the literature.
    Holzheimer RG; Dralle H
    Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Infectious complications in pediatric cancer patients].
    Lehrnbecher T; Laws HJ
    Klin Padiatr; 2005 Nov; 217 Suppl 1():S3-8. PubMed ID: 16288349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antimicrobial prophylaxis and therapy in neutropenia].
    Link H
    Mycoses; 2003; 46 Suppl 2():21-32. PubMed ID: 15055140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment and prevention of infections in cancer patients with neutropenia].
    Sinkó J
    Magy Onkol; 2011 Sep; 55(3):155-63. PubMed ID: 21918740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. A meta-analysis of 16 randomized, controlled trials.
    Kanda Y; Yamamoto R; Chizuka A; Hamaki T; Suguro M; Arai C; Matsuyama T; Takezako N; Miwa A; Kern W; Kami M; Akiyama H; Hirai H; Togawa A
    Cancer; 2000 Oct; 89(7):1611-25. PubMed ID: 11013378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why empirical therapy?
    Klastersky J
    J Antimicrob Chemother; 2009 May; 63 Suppl 1():i14-5. PubMed ID: 19372173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients.
    Oude Nijhuis C; Kamps WA; Daenen SM; Gietema JA; van der Graaf WT; Groen HJ; Vellenga E; Ten Vergert EM; Vermeulen KM; de Vries-Hospers HG; de Bont ES
    J Clin Oncol; 2005 Oct; 23(30):7437-44. PubMed ID: 16234511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Empiric antibiotic therapy for treatment of infection in patients with severe neutropenia].
    Bajko G; Kubiak A; Hansz J
    Acta Haematol Pol; 1995; 26(1):15-26. PubMed ID: 7747558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Febrile neutropenia in haematological malignancies.
    Sharma A; Lokeshwar N
    J Postgrad Med; 2005; 51 Suppl 1():S42-8. PubMed ID: 16519255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empiric treatment of fungal infections in the neutropenic host. Review of the literature and guidelines for use.
    Sugar AM
    Arch Intern Med; 1990 Nov; 150(11):2258-64. PubMed ID: 2241435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wait and see or rush and switch? New questions for the management of patients with febrile neutropenia receiving antifungal prophylaxis.
    Karthaus M; Hentrich M
    Mycoses; 2011 Jan; 54 Suppl 1():1-6. PubMed ID: 21126265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outpatient oral antibiotics for febrile neutropenic cancer patients.
    Ouvrier MJ; Thery JC; Blot E
    J Clin Oncol; 2006 Dec; 24(35):5614; author reply 5614-5. PubMed ID: 17158551
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes in the epidemiology of infections in patients with febrile neutropenia].
    Karthaus M; Carratala J
    Wien Med Wochenschr; 2001; 151(3-4):47-52. PubMed ID: 11789419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of invasive organ mycoses in patients with systemic hematologic diseases].
    Karthaus M; Böhme A
    Wien Med Wochenschr; 2001; 151(3-4):80-8. PubMed ID: 11789423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors.
    Kebudi R; Görgün O; Ayan I; Gürler N; Akici F; Töreci K
    Med Pediatr Oncol; 2001 Apr; 36(4):434-41. PubMed ID: 11260566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic approach to a patient with febrile neutropenia].
    Duraković N; Nemet D
    Lijec Vjesn; 2007; 129(10-11):344-50. PubMed ID: 18257335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk assessment in fever and neutropenia in children with cancer: What did we learn?
    te Poele EM; Tissing WJ; Kamps WA; de Bont ES
    Crit Rev Oncol Hematol; 2009 Oct; 72(1):45-55. PubMed ID: 19195908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infections in patients with multiple myeloma.
    Nucci M; Anaissie E
    Semin Hematol; 2009 Jul; 46(3):277-88. PubMed ID: 19549580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.